Mast cells involvement in the inflammation and fibrosis development of the TNBS-induced rat model of colitis.
BACKGROUND
Mast cells have been implicated in chronic inflammatory conditions resulting in fibrosis, such as Crohn disease. However, a link between inflammation, fibrosis and mast cells has not been demonstrated in human or animal intestinal diseases. This work was undertaken to analyze whether mast cells play a role in inflammation and fibrosis in the TNBS-induced rat colitis.


METHODS
Rats were rectally instilled 2,4,6,-trinitrobenzene sulfonic acid in ethanol, and immediately or 4 days later injected daily i.p. with nedocromil sodium, a mast cell stabilizer, compound 48/80, a mast cell activator, or saline. Rats were sacrificed 5 days post-TNBS, or on day 21. Intestinal inflammation and fibrosis were assessed by gross and histopathological evaluation. Colonic mast cell numbers (toluidine blue) and collagen (type I mRNA expression) were evaluated. Mast cell sonicate was added to rat colon fibroblasts. Fibroblast proliferation (3H-thymidine), collagen synthesis (3H-proline) and contractile activity (tridimensional collagen lattice contraction) were then assessed.


RESULTS
Nedocromil reduced inflammation and fibrosis possibly by decreasing mast cell numbers and activation and consequent collagen production. Compound 48/80 slightly enhanced the severity of the disease by activating mast cells. Mast cells increased fibroblast proliferation, collagen production and contractile activity.


CONCLUSIONS
Mast cells are involved in the gastrointestinal tract inflammation and fibrosis of the TNBS-colitis rats.
Xu
Xiang
X
Dept. of Pharmacology, School of Pharmacy, The Hebrew University-Hadassah Medical School, Jerusalem, Israel.
Weksler-Zangen
S
S
Pikarsky
A
A
Pappo
O
O
Wengrower
D
D
Bischoff
S C
SC
Pines
M
M
Rivkind
A
A
Goldin
E
E
Levi-Schaffer
F
F
D000818:Animals; D002455:Cell Division / Q000502:physiology; D002478:Cells, Cultured; D003092:Colitis / Q000473:pathology*; D003094:Collagen / Q000096:biosynthesis / Q000378:metabolism; D004195:Disease Models, Animal; D005347:Fibroblasts / Q000187:drug effects / Q000473:pathology*; D005355:Fibrosis / Q000473:pathology*; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D007211:Indoles; D018836:Inflammation Mediators / Q000502:physiology*; D007413:Intestinal Mucosa / Q000187:drug effects* / Q000473:pathology; D008297:Male; D008407:Mast Cells / Q000187:drug effects / Q000502:physiology*; D017835:Nedocromil / Q000494:pharmacology; D011336:Probability; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D011919:Rats, Inbred Strains; D012016:Reference Values
D007211:Indoles; D018836:Inflammation Mediators; D012333:RNA, Messenger; D017835:Nedocromil; C050115:1',3',3'-trimethyl-6-nitroindolene-2-spiro-2-benzopyran; D003094:Collagen